Category Business

Kezar Board Rejects Unsolicited Concentra Proposal and Implements Short-Term Stockholder Rights Plan

Kezar Life Sciences Board Unanimously Rejects Concentra’s Acquisition Proposal and Implements Limited Duration Stockholder Rights Plan Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company focused on developing novel small molecule therapeutics for immune-mediated diseases, announced today that its…

Read MoreKezar Board Rejects Unsolicited Concentra Proposal and Implements Short-Term Stockholder Rights Plan

Minze Health Secures $5.3 Million to Advance Prescription Digital Therapeutics and U.S. Market Commercialization

Minze Health Secures $5.3 Million in Funding to Advance Digital Health Solutions for Urology Minze Health, a leader in digital health solutions tailored for urology, has successfully raised $5.3 million in a funding round spearheaded by its current investors—White Fund,…

Read MoreMinze Health Secures $5.3 Million to Advance Prescription Digital Therapeutics and U.S. Market Commercialization

Modivcare and Tenovi Partner to Improve Respiratory Care with Hailie® Smart Inhalers

Modivcare Partners with Tenovi to Enhance Respiratory Care Using Adherium’s Hailie® Smart Inhalers Modivcare Inc., a prominent technology-enabled healthcare services company, has announced a partnership with Tenovi, a pioneer in cellular-connected remote monitoring solutions. This collaboration aims to enhance the…

Read MoreModivcare and Tenovi Partner to Improve Respiratory Care with Hailie® Smart Inhalers

Helfie AI Adds Healthcare Experts Antonin de Fougerolles and Cheryl Buxton to Board of Directors

Helfie AI, a global leader in mobile health technology, has strengthened its Board of Directors with the addition of two healthcare veterans. Antonin (Tony) de Fougerolles, PhD, a distinguished scientist known for his role as founding Chief Scientific Officer at…

Read MoreHelfie AI Adds Healthcare Experts Antonin de Fougerolles and Cheryl Buxton to Board of Directors

Viatris Secures Global Licensing Deal with Lexicon for Sotagliflozin Outside U.S. and Europe

Viatris Signs Exclusive Licensing Deal with Lexicon for Sotagliflozin Outside U.S. and Europe PITTSBURGH, Oct. 16, 2024 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) has reached an exclusive licensing agreement with Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to market sotagliflozin in all…

Read MoreViatris Secures Global Licensing Deal with Lexicon for Sotagliflozin Outside U.S. and Europe

MEDiC Life Sciences Partners with Hanmi on Cancer Biomarker Discovery, Secures Strategic Investment

MEDiC Life Sciences, a biotech startup based in Silicon Valley, has announced a new research collaboration with Hanmi Pharmaceutical, a prominent biopharmaceutical company in Korea. The partnership aims to identify cancer biomarkers for one of Hanmi’s clinical programs using MEDiC’s…

Read MoreMEDiC Life Sciences Partners with Hanmi on Cancer Biomarker Discovery, Secures Strategic Investment